Business Context and Reporting Period
This Form 8-K is a current report filed by Keros Therapeutics, Inc. on February 11, 2022. The filing serves as a Regulation FD disclosure regarding an upcoming corporate event rather than a periodic financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is an event notification and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely announces a scheduled presentation by company leadership.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Jasbir Seehra, President and Chief Executive Officer, is scheduled to present at the 11th Annual SVB Leerink Global Healthcare Conference.
- Date and Time: Friday, February 18, 2022, at 9:20 am ET.
- Legal Status: The information in this report and the accompanying press release (Exhibit 99.1) is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the SVB Leerink Global Healthcare Conference presentation (February 18, 2022, 9:20 am ET).
- Review the full text of the press release attached as Exhibit 99.1 for any additional details on the presentation topic.
- Confirm that no financial data is included in this specific 8-K filing; refer to the most recent 10-K or 10-Q for financial metrics.